Andrew Lee Rozelle, MD
Rheumatology · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rozelle’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A83950 · Current
Licensed to practise in California · since 2003 · expires 2027-07-31 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$121,944
Medicare paid this office $121,944 for 361 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 217 | $51,247 | $150 |
| New patient visit (60+ min) | 69 | $13,629 | $198 |
| Return visit (30+ min) | 105 | $13,291 | $105 |
| Short return visit (20+ min) | 75 | $7,203 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 250 | $5,625 | $14 |
See all 11 services
| Long return visit (40+ min) | 217 | $51,247 | $150 |
| New patient visit (60+ min) | 69 | $13,629 | $198 |
| Return visit (30+ min) | 105 | $13,291 | $105 |
| Short return visit (20+ min) | 75 | $7,203 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 250 | $5,625 | $14 |
| Aspiration and/or injection of fluid from large joint | 28 | $2,688 | $61 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 41 | $1,509 | $30 |
| Aspiration and/or injection of fluid from small joint | 16 | $1,083 | $43 |
| Influenza vaccine split virus, preservative free | 12 | $982 | $82 |
| Administration of influenza virus vaccine | 13 | $498 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | $202 | None |
Who their Medicare patients are
361 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 16% · Women 70% · Also on Medicaid 7% · Health risk score 1.13. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 63% · Coronary heart disease 25% · Diabetes 19% · Chronic kidney disease 19% · Atrial fibrillation 16% · Cancer 15% · Depression 13% · Heart failure 12% · COPD 7% · Stroke 5% · Dementia 4%.
The office billed $488,982, Medicare allowed $166,327 and paid $121,944; for 5,234 services of 30 kinds; $18,074 of it was for drugs given in the office and $103,871 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 361 | 5,234 | 76 | 1.13 | $488,982 | $121,944 |
| 2023 | 382 | 14,989 | 76 | 1.15 | $707,550 | $166,609 |
| 2022 | 421 | 18,760 | 76 | 1.00 | $787,939 | $191,744 |
| 2021 | 388 | 14,962 | 76 | 0.99 | $680,339 | $187,586 |
| 2020 | 367 | 11,695 | 75 | 1.14 | $527,016 | $148,110 |
| 2019 | 421 | 12,451 | 75 | 1.18 | $547,963 | $162,499 |
| 2018 | 396 | 9,787 | 74 | 1.17 | $472,534 | $140,001 |
| 2017 | 402 | 7,014 | 74 | 1.13 | $396,095 | $118,740 |
| 2016 | 380 | 2,806 | 75 | 1.10 | $329,321 | $95,094 |
| 2015 | 446 | 1,622 | 74 | 1.06 | $338,712 | $102,149 |
| 2014 | 403 | 1,616 | 75 | 1.12 | $313,555 | $93,456 |
| 2013 | 357 | 1,754 | 74 | 1.04 | $310,452 | $88,989 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 246 | $65,641 | $162 |
| Return visit (30+ min) | 152 | $21,370 | $106 |
| New patient visit (60+ min) | 48 | $9,237 | $192 |
| Aspiration and/or injection of fluid from large joint | 43 | $4,424 | $67 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 37 | $2,875 | $76 |
| Short return visit (20+ min) | 19 | $1,865 | $78 |
| Administration of influenza virus vaccine | 41 | $1,578 | $38 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 29 | $1,433 | $30 |
| Aspiration and/or injection of fluid from small joint | 19 | $1,397 | $47 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $315 | None |
2022: 16 services
| Long return visit (40+ min) | 152 | $36,077 | $161 |
| Return visit (30+ min) | 189 | $29,280 | $111 |
| New patient visit (60+ min) | 89 | $17,708 | $199 |
| Aspiration and/or injection of fluid from large joint | 53 | $5,444 | $67 |
| Short return visit (20+ min) | 60 | $5,270 | $74 |
| New patient visit (45+ min) | 25 | $3,656 | $146 |
| Extended patient service without direct patient contact, first hour | 29 | $2,699 | $93 |
| Pneumococcal vaccine, 23-valent | 19 | $2,499 | $132 |
| Aspiration and/or injection of fluid from small joint | 24 | $1,875 | $41 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 22 | $1,546 | $70 |
| Administration of influenza virus vaccine | 24 | $900 | $37 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $820 | $30 |
| Aspiration and/or injection of fluid from medium joint | 11 | $730 | $52 |
| Administration of pneumococcal vaccine | 21 | $714 | $34 |
| Injection into tendon or ligament | 11 | $601 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | $336 | None |
2021: 17 services
| Return visit (30+ min) | 213 | $35,602 | $113 |
| Long return visit (40+ min) | 95 | $21,401 | $162 |
| New patient visit (60+ min) | 72 | $15,106 | $210 |
| New patient visit (45+ min) | 52 | $8,060 | $155 |
| Short return visit (20+ min) | 63 | $6,530 | $84 |
| Aspiration and/or injection of fluid from large joint | 50 | $5,829 | $65 |
| Extended patient service without direct patient contact, first hour | 26 | $2,584 | $99 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,614 | $108 |
| Aspiration and/or injection of fluid from small joint | 23 | $1,510 | $43 |
| Pneumococcal vaccine, 23-valent | 11 | $1,385 | $126 |
| Influenza vaccine split virus, preservative free | 21 | $1,370 | $65 |
| Aspiration and/or injection of fluid from medium joint | 23 | $1,219 | $47 |
| Injection into tendon or ligament | 18 | $972 | $46 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $595 | $50 |
| Administration of influenza virus vaccine | 23 | $499 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $429 | None |
| Administration of pneumococcal vaccine | 13 | $285 | $22 |
2020: 17 services
| Return visit (30+ min) | 193 | $26,476 | $92 |
| New patient visit (45+ min) | 80 | $11,318 | $141 |
| Short return visit (20+ min) | 84 | $6,568 | $62 |
| Long return visit (40+ min) | 37 | $5,731 | $133 |
| Aspiration and/or injection of fluid from large joint | 35 | $4,203 | $66 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $4,126 | $106 |
| Extended patient service without direct patient contact, first hour | 36 | $3,754 | $104 |
| Pneumococcal vaccine, 23-valent | 26 | $3,046 | $117 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,725 | $69 |
| Influenza vaccine split virus, preservative free | 26 | $1,571 | $60 |
| Aspiration and/or injection of fluid from small joint | 19 | $1,051 | $44 |
| Aspiration and/or injection of fluid from medium joint | 14 | $772 | $51 |
| New patient visit (30+ min) | 11 | $772 | $70 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 42 | $653 | $13 |
| Administration of influenza virus vaccine | 29 | $603 | $21 |
| Administration of pneumococcal vaccine | 28 | $580 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $320 | None |
2019: 15 services
| Return visit (30+ min) | 243 | $35,585 | $92 |
| New patient visit (45+ min) | 107 | $14,995 | $140 |
| Short return visit (20+ min) | 115 | $9,144 | $60 |
| Aspiration and/or injection of fluid from large joint | 50 | $6,045 | $62 |
| Long return visit (40+ min) | 37 | $5,387 | $138 |
| Extended patient service without direct patient contact, first hour | 37 | $3,981 | $102 |
| New patient visit (60+ min) | 16 | $2,951 | $184 |
| Pneumococcal vaccine, 23-valent | 17 | $1,884 | $111 |
| Aspiration and/or injection of fluid from small joint | 24 | $1,569 | $37 |
| New patient visit (30+ min) | 14 | $1,244 | $89 |
| Aspiration and/or injection of fluid from medium joint | 21 | $1,044 | $47 |
| Influenza vaccine split virus, preservative free | 19 | $1,006 | $53 |
| Administration of influenza virus vaccine | 21 | $428 | $20 |
| Administration of pneumococcal vaccine | 20 | $409 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $172 | None |
2018: 14 services
| Return visit (30+ min) | 217 | $34,042 | $91 |
| Short return visit (20+ min) | 129 | $11,259 | $58 |
| New patient visit (45+ min) | 85 | $10,517 | $124 |
| Aspiration and/or injection of fluid from large joint | 60 | $5,747 | $60 |
| Long return visit (40+ min) | 32 | $4,086 | $124 |
| New patient visit (60+ min) | 17 | $3,026 | $178 |
| New patient visit (30+ min) | 17 | $1,507 | $89 |
| Aspiration and/or injection of fluid from small joint | 25 | $1,315 | $39 |
| Influenza vaccine split virus, preservative free | 28 | $1,235 | $44 |
| Aspiration and/or injection of fluid from medium joint | 21 | $1,084 | $45 |
| Administration of influenza virus vaccine | 34 | $875 | $26 |
| Injection into tendon or ligament | 13 | $522 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $399 | None |
| Administration of pneumococcal vaccine | 11 | $283 | $26 |
2017: 16 services
| Return visit (30+ min) | 235 | $33,975 | $90 |
| New patient visit (45+ min) | 85 | $11,708 | $138 |
| Short return visit (20+ min) | 127 | $10,803 | $59 |
| Long return visit (40+ min) | 49 | $6,772 | $119 |
| Aspiration and/or injection of fluid from large joint | 51 | $5,200 | $61 |
| New patient visit (60+ min) | 14 | $2,515 | $180 |
| Pneumococcal vaccine, 13-valent | 13 | $2,420 | $186 |
| New patient visit (30+ min) | 14 | $1,168 | $83 |
| Aspiration and/or injection of fluid from small joint | 21 | $1,148 | $43 |
| Influenza vaccine split virus, preservative free | 26 | $1,133 | $44 |
| Pneumococcal vaccine, 23-valent | 11 | $1,066 | $97 |
| Administration of influenza virus vaccine | 30 | $963 | $32 |
| Aspiration and/or injection of fluid from medium joint | 16 | $782 | $46 |
| Injection into tendon or ligament | 15 | $759 | $45 |
| Administration of pneumococcal vaccine | 24 | $729 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 87 | $496 | None |
2016: 15 services
| Return visit (30+ min) | 220 | $32,748 | $89 |
| New patient visit (45+ min) | 86 | $11,574 | $135 |
| Short return visit (20+ min) | 115 | $10,911 | $61 |
| Long return visit (40+ min) | 52 | $8,316 | $128 |
| Aspiration and/or injection of fluid from large joint | 64 | $6,060 | $57 |
| New patient visit (60+ min) | 15 | $2,696 | $180 |
| New patient visit (30+ min) | 23 | $1,921 | $84 |
| Pneumococcal vaccine, 23-valent | 19 | $1,646 | $87 |
| Aspiration and/or injection of fluid from medium joint | 27 | $1,584 | $47 |
| Administration of influenza virus vaccine | 52 | $1,576 | $30 |
| Influenza vaccine split virus, preservative free | 42 | $1,526 | $36 |
| Injection into tendon or ligament | 17 | $1,045 | $50 |
| Aspiration and/or injection of fluid from small joint | 19 | $950 | $40 |
| Administration of pneumococcal vaccine | 25 | $758 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $591 | None |
2015: 16 services
| Return visit (30+ min) | 223 | $36,551 | $94 |
| New patient visit (45+ min) | 104 | $15,491 | $149 |
| Short return visit (20+ min) | 118 | $10,422 | $63 |
| Long return visit (40+ min) | 66 | $9,541 | $131 |
| Aspiration and/or injection of fluid from large joint | 69 | $6,327 | $58 |
| New patient visit (60+ min) | 24 | $4,591 | $191 |
| Pneumococcal vaccine, 13-valent | 20 | $3,149 | $150 |
| New patient visit (30+ min) | 20 | $1,952 | $98 |
| Administration of influenza virus vaccine | 44 | $1,410 | $31 |
| Influenza vaccine split virus, preservative free | 35 | $1,275 | $35 |
| Aspiration and/or injection of fluid from medium joint | 24 | $1,209 | $43 |
| Pneumococcal vaccine, 23-valent | 18 | $1,198 | $67 |
| Administration of pneumococcal vaccine | 38 | $1,186 | $30 |
| Aspiration and/or injection of fluid from small joint | 22 | $1,186 | $41 |
| New patient visit (15+ min) | 11 | $721 | $66 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 98 | $560 | None |
2014: 14 services
| Return visit (30+ min) | 210 | $29,366 | $90 |
| Short return visit (20+ min) | 141 | $12,001 | $58 |
| New patient visit (45+ min) | 78 | $10,986 | $141 |
| Long return visit (40+ min) | 57 | $8,687 | $122 |
| Aspiration and/or injection of fluid from large joint | 78 | $7,161 | $56 |
| Pneumococcal vaccine, 13-valent | 46 | $6,877 | $146 |
| New patient visit (60+ min) | 31 | $5,733 | $185 |
| Administration of pneumococcal vaccine | 47 | $1,580 | $30 |
| New patient visit (30+ min) | 17 | $1,489 | $88 |
| Administration of influenza virus vaccine | 32 | $1,003 | $30 |
| Aspiration and/or injection of fluid from medium joint | 17 | $921 | $42 |
| Aspiration and/or injection of fluid from small joint | 18 | $898 | $36 |
| Influenza vaccine split virus, preservative free | 27 | $881 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 87 | $531 | None |
2013: 14 services
| Return visit (30+ min) | 174 | $27,918 | $94 |
| New patient visit (45+ min) | 96 | $12,975 | $135 |
| Short return visit (20+ min) | 129 | $12,668 | $59 |
| Aspiration and/or injection of fluid from large joint | 74 | $6,678 | $49 |
| Long return visit (40+ min) | 32 | $4,799 | $126 |
| New patient visit (60+ min) | 26 | $4,686 | $180 |
| New patient visit (30+ min) | 25 | $2,473 | $99 |
| Aspiration and/or injection of fluid from medium joint | 26 | $1,923 | $58 |
| Pneumococcal vaccine, 13-valent | 13 | $1,849 | $142 |
| Aspiration and/or injection of fluid from small joint | 17 | $860 | $39 |
| Administration of pneumococcal vaccine | 15 | $456 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $449 | None |
| Injection, triamcinolone hexacetonide, per 5 mg | 28 | $178 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 13 | $152 | None |
Drugs they prescribed that Part D paid
$2,481,571
Pharmacies billed $2,481,571 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (97 of 1,996) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,562 generic and fewer than 11 brand-name prescriptions · $2,481,571 in drug cost · 28 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 63 | $427,637 | $6,788 |
| Enbrel Sureclick | 54 | $395,013 | $7,315 |
| Xeljanz Xr | 44 | $323,955 | $7,363 |
| Enbrel | 28 | $202,252 | $7,223 |
| Orencia Clickject | 36 | $202,070 | $5,613 |
See all 37 drugs
| Humira(Cf) | 63 | $427,637 | $6,788 |
| Enbrel Sureclick | 54 | $395,013 | $7,315 |
| Xeljanz Xr | 44 | $323,955 | $7,363 |
| Enbrel | 28 | $202,252 | $7,223 |
| Orencia Clickject | 36 | $202,070 | $5,613 |
| Humira | 27 | $179,339 | $6,642 |
| Humira(Cf) | 21 | $152,298 | $7,252 |
| Taltz | 13 | $88,357 | $6,797 |
| Xeljanz | 13 | $85,093 | $6,546 |
| Orencia | 15 | $83,239 | $5,549 |
| Otezla | 12 | $68,271 | $5,689 |
| Methotrexate | 268 | $9,528 | $36 |
| Mycophenolate Mofetil | 24 | $4,047 | $169 |
| Hydroxychloroquine Sulfate | 131 | $3,750 | $29 |
| Probenecid | 30 | $3,281 | $109 |
| Prednisone | 284 | $3,047 | $11 |
| Colchicine | 33 | $2,866 | $87 |
| Celecoxib | 43 | $2,418 | $56 |
| Allopurinol | 173 | $2,284 | $13 |
| Leflunomide | 26 | $2,009 | $77 |
| Cevimeline | 12 | $1,896 | $158 |
| Febuxostat | 15 | $1,429 | $95 |
| Leucovorin | 38 | $1,057 | $28 |
| Duloxetine | 40 | $1,026 | $26 |
| Hydrocodone-Acetaminophen | 55 | $967 | $18 |
| Sulfasalazine | 20 | $946 | $47 |
| Alendronate | 80 | $800 | $10 |
| Folic Acid | 53 | $731 | $14 |
| Sulfasalazine Dr | 13 | $570 | $44 |
| Omeprazole | 36 | $467 | $13 |
| Tramadol | 26 | $438 | $17 |
| Venlafaxine Hcl Er | 14 | $379 | $27 |
| Pantoprazole | 24 | $353 | $15 |
| Methotrexate | 13 | $298 | $23 |
| Nabumetone | 14 | $229 | $16 |
| Sulfamethoxazole-Trimethoprim | 19 | $167 | $9 |
| Meloxicam | 14 | $40 | $3 |
Year by year
| 2024 | 1,996 | 326 | 5% (97) | None | $2,481,571 |
| 2023 | 2,330 | 335 | 5% (108) | 18% | $2,454,807 |
| 2022 | 2,269 | 349 | 5% (120) | 17% | $1,972,952 |
| 2021 | 2,155 | 312 | 5% (112) | 16% | $1,690,927 |
| 2020 | 2,021 | 295 | 6% (111) | None | $1,474,927 |
| 2019 | 2,014 | 295 | 5% (94) | 18% | $1,086,844 |
| 2018 | 2,132 | 294 | 5% (111) | None | $1,081,842 |
| 2017 | 2,046 | 281 | 5% (107) | 18% | $909,313 |
| 2016 | 2,018 | 261 | 6% (129) | None | $718,036 |
| 2015 | 2,114 | 287 | 8% (171) | 25% | $929,140 |
| 2014 | 1,983 | 265 | 7% (138) | 27% | $751,767 |
| 2013 | 1,767 | 229 | 6% (104) | 27% | $457,405 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Humira(Cf) | 61 | $426,442 | $6,991 |
| Xeljanz Xr | 55 | $386,605 | $7,029 |
| Enbrel Sureclick | 45 | $318,202 | $7,071 |
| Humira(Cf) | 32 | $237,826 | $7,432 |
| Enbrel | 23 | $212,331 | $9,232 |
| Humira | 25 | $194,823 | $7,793 |
| Orencia Clickject | 27 | $150,569 | $5,577 |
| Xeljanz | 13 | $78,170 | $6,013 |
| Simponi | 12 | $74,201 | $6,183 |
| Otezla | 12 | $59,627 | $4,969 |
| Orencia | 11 | $57,908 | $5,264 |
| Methotrexate | 366 | $16,563 | $45 |
| Colchicine | 48 | $7,413 | $154 |
| Hydroxychloroquine Sulfate | 123 | $6,648 | $54 |
| Probenecid | 32 | $4,847 | $151 |
| Prednisone | 366 | $4,634 | $13 |
| Celecoxib | 50 | $4,134 | $83 |
| Allopurinol | 190 | $3,425 | $18 |
| Mycophenolate Mofetil | 25 | $3,278 | $131 |
| Febuxostat | 24 | $2,961 | $123 |
| Sulfasalazine | 37 | $1,869 | $51 |
| Leflunomide | 15 | $1,588 | $106 |
| Duloxetine | 38 | $1,286 | $34 |
| Alendronate | 105 | $1,133 | $11 |
| Leucovorin | 27 | $972 | $36 |
| Omeprazole | 60 | $673 | $11 |
| Hydrocodone-Acetaminophen | 53 | $666 | $13 |
| Venlafaxine Hcl Er | 15 | $653 | $44 |
| Nabumetone | 23 | $618 | $27 |
| Sulfasalazine Dr | 12 | $536 | $45 |
| Pantoprazole | 25 | $522 | $21 |
| Tramadol | 37 | $508 | $14 |
| Gabapentin | 30 | $468 | $16 |
| Pregabalin | 11 | $420 | $38 |
| Methotrexate | 19 | $380 | $20 |
| Acetaminophen-Codeine | 12 | $361 | $30 |
| Folic Acid | 56 | $358 | $6 |
| Paxlovid (Eua) | 12 | $126 | $10 |
| Meloxicam | 19 | $97 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $34 | $3 |
2022: 39 drugs
| Xeljanz Xr | 55 | $350,995 | $6,382 |
| Humira(Cf) | 49 | $326,751 | $6,668 |
| Humira(Cf) | 40 | $262,995 | $6,575 |
| Enbrel Sureclick | 35 | $220,017 | $6,286 |
| Humira | 26 | $178,227 | $6,855 |
| Enbrel | 15 | $131,748 | $8,783 |
| Orencia Clickject | 16 | $84,832 | $5,302 |
| Cosentyx (2 Syringes) | 12 | $82,141 | $6,845 |
| Benlysta | 14 | $63,152 | $4,511 |
| Orencia | 11 | $54,630 | $4,966 |
| Methotrexate | 295 | $14,664 | $50 |
| Colchicine | 56 | $11,423 | $204 |
| Hydroxychloroquine Sulfate | 129 | $8,997 | $70 |
| Celebrex | 13 | $7,354 | $566 |
| Mycophenolate Mofetil | 38 | $5,817 | $153 |
| Prednisone | 367 | $5,336 | $15 |
| Febuxostat | 22 | $3,783 | $172 |
| Probenecid | 29 | $3,653 | $126 |
| Celecoxib | 52 | $3,184 | $61 |
| Allopurinol | 189 | $3,124 | $17 |
| Duloxetine | 59 | $2,447 | $41 |
| Leflunomide | 17 | $2,421 | $142 |
| Sulfasalazine | 35 | $1,591 | $45 |
| Sulfasalazine Dr | 16 | $1,269 | $79 |
| Hydrocodone-Acetaminophen | 78 | $1,269 | $16 |
| Alendronate | 107 | $976 | $9 |
| Morphine Sulfate Er | 11 | $962 | $87 |
| Nabumetone | 18 | $855 | $47 |
| Gabapentin | 52 | $745 | $14 |
| Leucovorin | 28 | $727 | $26 |
| Omeprazole | 55 | $723 | $13 |
| Pantoprazole | 19 | $527 | $28 |
| Venlafaxine Hcl Er | 12 | $442 | $37 |
| Folic Acid | 60 | $391 | $7 |
| Tramadol | 17 | $348 | $20 |
| Sulfamethoxazole-Trimethoprim | 19 | $332 | $17 |
| Acetaminophen-Codeine | 11 | $276 | $25 |
| Methotrexate | 13 | $201 | $15 |
| Meloxicam | 15 | $82 | $5 |
2021: 36 drugs
| Xeljanz Xr | 54 | $298,384 | $5,526 |
| Humira(Cf) | 29 | $222,205 | $7,662 |
| Enbrel Sureclick | 34 | $204,695 | $6,020 |
| Humira(Cf) | 27 | $195,861 | $7,254 |
| Humira | 21 | $141,342 | $6,731 |
| Enbrel | 16 | $134,453 | $8,403 |
| Actemra | 22 | $72,508 | $3,296 |
| Kineret | 14 | $65,357 | $4,668 |
| Methotrexate | 264 | $11,740 | $44 |
| Hydroxychloroquine Sulfate | 155 | $9,636 | $62 |
| Colchicine | 56 | $9,632 | $172 |
| Celebrex | 11 | $5,997 | $545 |
| Febuxostat | 16 | $5,880 | $368 |
| Mycophenolate Mofetil | 33 | $5,707 | $173 |
| Prednisone | 384 | $4,626 | $12 |
| Probenecid | 29 | $4,080 | $141 |
| Allopurinol | 195 | $3,424 | $18 |
| Leflunomide | 28 | $2,696 | $96 |
| Sulfasalazine | 41 | $2,070 | $50 |
| Duloxetine | 57 | $1,951 | $34 |
| Celecoxib | 45 | $1,935 | $43 |
| Hydrocodone-Acetaminophen | 79 | $1,738 | $22 |
| Azathioprine | 14 | $1,423 | $102 |
| Morphine Sulfate Er | 12 | $1,118 | $93 |
| Alendronate | 88 | $978 | $11 |
| Sulfasalazine Dr | 12 | $738 | $61 |
| Gabapentin | 31 | $528 | $17 |
| Pantoprazole | 26 | $520 | $20 |
| Omeprazole | 53 | $459 | $9 |
| Leucovorin | 21 | $453 | $22 |
| Nabumetone | 14 | $432 | $31 |
| Diclofenac | 11 | $243 | $22 |
| Sulfamethoxazole-Trimethoprim | 30 | $235 | $8 |
| Meloxicam | 27 | $198 | $7 |
| Folic Acid | 29 | $180 | $6 |
| Tramadol | 12 | $115 | $10 |
2020: 37 drugs
| Xeljanz Xr | 51 | $290,995 | $5,706 |
| Enbrel Sureclick | 36 | $211,771 | $5,883 |
| Humira | 13 | $185,775 | $14,290 |
| Humira(Cf) | 17 | $144,367 | $8,492 |
| Humira(Cf) | 16 | $129,466 | $8,092 |
| Enbrel | 12 | $111,125 | $9,260 |
| Kineret | 19 | $83,992 | $4,421 |
| Otezla | 21 | $78,781 | $3,751 |
| Colchicine | 46 | $15,203 | $330 |
| Colcrys | 26 | $13,055 | $502 |
| Hydroxychloroquine Sulfate | 171 | $12,477 | $73 |
| Methotrexate | 280 | $12,119 | $43 |
| Febuxostat | 26 | $9,853 | $379 |
| Prednisone | 331 | $5,024 | $15 |
| Leflunomide | 26 | $4,355 | $168 |
| Plaquenil | 12 | $3,861 | $322 |
| Probenecid | 36 | $3,716 | $103 |
| Celecoxib | 65 | $3,551 | $55 |
| Allopurinol | 176 | $2,946 | $17 |
| Duloxetine | 59 | $2,646 | $45 |
| Azathioprine | 28 | $2,296 | $82 |
| Mycophenolate Mofetil | 17 | $1,856 | $109 |
| Hydrocodone-Acetaminophen | 72 | $1,779 | $25 |
| Diclofenac | 28 | $1,290 | $46 |
| Sulfasalazine | 22 | $1,250 | $57 |
| Alendronate | 105 | $1,147 | $11 |
| Morphine Sulfate Er | 12 | $1,118 | $93 |
| Pregabalin | 16 | $1,027 | $64 |
| Omeprazole | 41 | $654 | $16 |
| Pantoprazole | 17 | $473 | $28 |
| Leucovorin | 16 | $442 | $28 |
| Nabumetone | 17 | $333 | $20 |
| Gabapentin | 22 | $167 | $8 |
| Sulfamethoxazole-Trimethoprim | 12 | $154 | $13 |
| Meloxicam | 16 | $98 | $6 |
| Tramadol | 13 | $93 | $7 |
| Cyclobenzaprine | 12 | $26 | $2 |
2019: 31 drugs
| Humira | 38 | $335,019 | $8,816 |
| Humira(Cf) | 19 | $98,915 | $5,206 |
| Kineret | 23 | $96,991 | $4,217 |
| Xeljanz Xr | 21 | $94,875 | $4,518 |
| Enbrel Sureclick | 18 | $91,009 | $5,056 |
| Uloric | 24 | $19,966 | $832 |
| Colcrys | 34 | $13,728 | $404 |
| Hydroxychloroquine Sulfate | 134 | $13,374 | $100 |
| Colchicine | 41 | $12,971 | $316 |
| Methotrexate | 319 | $12,610 | $40 |
| Leflunomide | 22 | $5,413 | $246 |
| Prednisone | 342 | $5,313 | $16 |
| Celecoxib | 71 | $4,897 | $69 |
| Allopurinol | 181 | $2,872 | $16 |
| Diclofenac | 51 | $2,800 | $55 |
| Probenecid | 29 | $2,498 | $86 |
| Duloxetine | 47 | $2,304 | $49 |
| Mycophenolate Mofetil | 17 | $1,683 | $99 |
| Azathioprine | 20 | $1,347 | $67 |
| Hydrocodone-Acetaminophen | 56 | $1,150 | $21 |
| Morphine Sulfate Er | 12 | $1,118 | $93 |
| Alendronate | 108 | $1,090 | $10 |
| Omeprazole | 49 | $882 | $18 |
| Sulfasalazine | 23 | $867 | $38 |
| Gabapentin | 22 | $652 | $30 |
| Nabumetone | 16 | $645 | $40 |
| Entecavir | 11 | $583 | $53 |
| Leucovorin | 14 | $435 | $31 |
| Sulfamethoxazole-Trimethoprim | 26 | $311 | $12 |
| Methylprednisolone | 15 | $163 | $11 |
| Tramadol | 16 | $142 | $9 |
2018: 36 drugs
| Humira | 51 | $293,431 | $5,754 |
| Enbrel Sureclick | 21 | $101,776 | $4,846 |
| Xeljanz Xr | 20 | $87,229 | $4,361 |
| Kineret | 14 | $57,404 | $4,100 |
| Uloric | 53 | $34,677 | $654 |
| Hydroxychloroquine Sulfate | 180 | $19,125 | $106 |
| Methotrexate | 346 | $17,436 | $50 |
| Colcrys | 27 | $12,966 | $480 |
| Colchicine | 30 | $11,718 | $391 |
| Lyrica | 14 | $10,700 | $764 |
| Otrexup | 14 | $9,213 | $658 |
| Celecoxib | 58 | $8,302 | $143 |
| Leflunomide | 31 | $6,361 | $205 |
| Prednisone | 334 | $5,094 | $15 |
| Duloxetine | 65 | $4,172 | $64 |
| Mycophenolate Mofetil | 23 | $3,911 | $170 |
| Allopurinol | 139 | $2,515 | $18 |
| Morphine Sulfate Er | 11 | $2,123 | $193 |
| Hydrocodone-Acetaminophen | 68 | $2,090 | $31 |
| Voltaren | 16 | $1,443 | $90 |
| Gabapentin | 58 | $1,375 | $24 |
| Azathioprine | 13 | $1,284 | $99 |
| Sulfasalazine Dr | 12 | $1,087 | $91 |
| Sulfasalazine | 33 | $1,070 | $32 |
| Diclofenac | 25 | $1,060 | $42 |
| Probenecid | 20 | $1,036 | $52 |
| Alendronate | 107 | $798 | $7 |
| Omeprazole | 59 | $720 | $12 |
| Venlafaxine Hcl Er | 16 | $552 | $35 |
| Nifedipine Er | 13 | $351 | $27 |
| Tramadol | 14 | $313 | $22 |
| Pantoprazole | 30 | $271 | $9 |
| Sulfamethoxazole-Trimethoprim | 20 | $197 | $10 |
| Meloxicam | 13 | $125 | $10 |
| Methylprednisolone | 11 | $123 | $11 |
| Ibuprofen | 13 | $83 | $6 |
2017: 35 drugs
| Enbrel Sureclick | 38 | $171,179 | $4,505 |
| Humira | 37 | $168,518 | $4,555 |
| Kineret | 14 | $52,610 | $3,758 |
| Actemra | 13 | $50,798 | $3,908 |
| Orencia | 13 | $49,578 | $3,814 |
| Uloric | 40 | $25,133 | $628 |
| Hydroxychloroquine Sulfate | 182 | $22,355 | $123 |
| Methotrexate | 292 | $15,277 | $52 |
| Colchicine | 40 | $11,803 | $295 |
| Otrexup | 15 | $11,009 | $734 |
| Colcrys | 27 | $10,862 | $402 |
| Leflunomide | 21 | $6,921 | $330 |
| Lyrica | 14 | $6,481 | $463 |
| Prednisone | 362 | $5,616 | $16 |
| Celecoxib | 34 | $5,330 | $157 |
| Allopurinol | 144 | $3,469 | $24 |
| Mycophenolate Mofetil | 13 | $3,086 | $237 |
| Azathioprine | 28 | $2,776 | $99 |
| Morphine Sulfate Er | 12 | $2,763 | $230 |
| Duloxetine | 57 | $2,645 | $46 |
| Hydrocodone-Acetaminophen | 66 | $1,404 | $21 |
| Sulfasalazine | 40 | $1,216 | $30 |
| Voltaren | 17 | $997 | $59 |
| Alendronate | 124 | $938 | $8 |
| Probenecid | 18 | $902 | $50 |
| Gabapentin | 42 | $715 | $17 |
| Diclofenac | 11 | $647 | $59 |
| Omeprazole | 90 | $640 | $7 |
| Pantoprazole | 27 | $394 | $15 |
| Venlafaxine Hcl Er | 11 | $366 | $33 |
| Acetaminophen-Codeine | 13 | $243 | $19 |
| Sulfamethoxazole-Trimethoprim | 18 | $209 | $12 |
| Methylprednisolone | 12 | $167 | $14 |
| Nifedipine Er | 12 | $106 | $9 |
| Meloxicam | 11 | $50 | $5 |
2016: 28 drugs
| Enbrel | 49 | $276,107 | $5,635 |
| Humira | 40 | $156,208 | $3,905 |
| Hydroxychloroquine Sulfate | 186 | $27,246 | $146 |
| Uloric | 44 | $22,538 | $512 |
| Methotrexate | 259 | $12,408 | $48 |
| Colchicine | 51 | $12,275 | $241 |
| Otrexup | 17 | $10,039 | $591 |
| Lyrica | 15 | $6,858 | $457 |
| Prednisone | 435 | $6,578 | $15 |
| Leflunomide | 28 | $5,060 | $181 |
| Celecoxib | 12 | $4,027 | $336 |
| Allopurinol | 149 | $3,412 | $23 |
| Azathioprine | 25 | $2,413 | $97 |
| Hydrocodone-Acetaminophen | 67 | $2,089 | $31 |
| Duloxetine | 46 | $1,874 | $41 |
| Voltaren | 31 | $1,722 | $56 |
| Gabapentin | 55 | $1,372 | $25 |
| Sulfasalazine | 34 | $1,088 | $32 |
| Diclofenac | 17 | $987 | $58 |
| Omeprazole | 65 | $722 | $11 |
| Tramadol | 25 | $657 | $26 |
| Methylprednisolone | 32 | $624 | $19 |
| Sulfasalazine Dr | 11 | $506 | $46 |
| Alendronate | 79 | $457 | $6 |
| Venlafaxine Hcl Er | 16 | $447 | $28 |
| Pantoprazole | 19 | $385 | $20 |
| Acetaminophen-Codeine | 22 | $366 | $17 |
| Sulfamethoxazole-Trimethoprim | 21 | $218 | $10 |
2015: 30 drugs
| Enbrel | None | 69 | $312,685 | $4,532 |
| Gammagard Liquid | Immune globulin | 12 | $220,077 | $18,340 |
| Humira | None | 49 | $198,741 | $4,056 |
| Hydroxychloroquine Sulfate | None | 185 | $25,910 | $140 |
| Methotrexate | None | 293 | $18,595 | $63 |
| Uloric | None | 24 | $10,156 | $423 |
| Colchicine | None | 32 | $8,219 | $257 |
| Prednisone | None | 444 | $6,478 | $15 |
| Colcrys | None | 18 | $6,106 | $339 |
| Celecoxib | None | 21 | $5,253 | $250 |
| Duloxetine | None | 28 | $4,229 | $151 |
| Lyrica | None | 15 | $4,152 | $277 |
| Leflunomide | None | 43 | $3,590 | $83 |
| Allopurinol | None | 165 | $3,071 | $19 |
| Hydrocodone-Acetaminophen | None | 86 | $2,605 | $30 |
| Voltaren | None | 39 | $2,445 | $63 |
| Morphine Sulfate Er | None | 14 | $2,396 | $171 |
| Venlafaxine Hcl Er | None | 26 | $2,021 | $78 |
| Sulfasalazine | None | 42 | $1,304 | $31 |
| Mycophenolate Mofetil | None | 15 | $1,256 | $84 |
| Gabapentin | None | 46 | $1,053 | $23 |
| Azathioprine | None | 17 | $942 | $55 |
| Acetaminophen-Codeine | None | 29 | $808 | $28 |
| Probenecid | None | 22 | $766 | $35 |
| Omeprazole | None | 79 | $708 | $9 |
| Tramadol | None | 26 | $602 | $23 |
| Alendronate | None | 77 | $498 | $6 |
| Pantoprazole | None | 24 | $308 | $13 |
| Methylprednisolone | None | 15 | $291 | $19 |
| Sulfamethoxazole-Trimethoprim | None | 11 | $134 | $12 |
2014: 25 drugs
| Gammagard Liquid | Immune globulin | 35 | $265,747 | $7,593 |
| Enbrel | None | 49 | $159,177 | $3,249 |
| Humira | None | 47 | $155,383 | $3,306 |
| Methotrexate | None | 291 | $21,127 | $73 |
| Colcrys | None | 62 | $18,227 | $294 |
| Uloric | None | 40 | $10,729 | $268 |
| Duloxetine | None | 16 | $6,959 | $435 |
| Lyrica | None | 19 | $6,913 | $364 |
| Prednisone | None | 410 | $6,284 | $15 |
| Hydroxychloroquine Sulfate | None | 183 | $4,245 | $23 |
| Voltaren | None | 46 | $2,770 | $60 |
| Allopurinol | None | 172 | $1,990 | $12 |
| Hydrocodone-Acetaminophen | None | 75 | $1,922 | $26 |
| Gabapentin | None | 47 | $1,275 | $27 |
| Leflunomide | None | 32 | $1,196 | $37 |
| Sulfasalazine | None | 32 | $1,079 | $34 |
| Omeprazole | None | 70 | $662 | $9 |
| Azathioprine | None | 23 | $653 | $28 |
| Venlafaxine Hcl Er | None | 25 | $604 | $24 |
| Alendronate | None | 66 | $584 | $9 |
| Acetaminophen-Codeine | None | 17 | $433 | $25 |
| Isoniazid | None | 23 | $313 | $14 |
| Tramadol | None | 30 | $301 | $10 |
| Sulfamethoxazole-Trimethoprim | None | 15 | $109 | $7 |
| Sodium Chloride | None | 11 | $109 | $10 |
2013: 25 drugs
| Humira | None | 49 | $129,855 | $2,650 |
| Enbrel | None | 42 | $117,864 | $2,806 |
| Gammagard Liquid | Immune globulin | 15 | $105,202 | $7,013 |
| Colcrys | None | 63 | $18,315 | $291 |
| Cymbalta | None | 29 | $16,112 | $556 |
| Methotrexate | None | 239 | $14,128 | $59 |
| Uloric | None | 26 | $5,909 | $227 |
| Lyrica | None | 17 | $5,723 | $337 |
| Prednisone | None | 419 | $4,444 | $11 |
| Lidoderm | None | 11 | $2,940 | $267 |
| Hydroxychloroquine Sulfate | None | 147 | $2,858 | $19 |
| Celebrex | None | 11 | $2,291 | $208 |
| Venlafaxine Hcl Er | None | 28 | $2,246 | $80 |
| Voltaren | None | 24 | $2,182 | $91 |
| Hydrocodone-Acetaminophen | None | 62 | $1,575 | $25 |
| Allopurinol | None | 129 | $1,422 | $11 |
| Alendronate | None | 88 | $994 | $11 |
| Gabapentin | None | 32 | $960 | $30 |
| Omeprazole | None | 96 | $950 | $10 |
| Leflunomide | None | 24 | $775 | $32 |
| Methylprednisolone | None | 14 | $450 | $32 |
| Sulfasalazine | None | 16 | $393 | $25 |
| Nabumetone | None | 17 | $304 | $18 |
| Morphine Sulfate | None | 12 | $247 | $21 |
| Tramadol | None | 17 | $157 | $9 |
Money from drug and device companies
$221 in 2025
| 2025 | 2 | 14 | None | $221 |
| 2024 | 1 | 3 | None | $68 |
| 2022 | 1 | 1 | None | $120 |
| 2019 | 1 | 1 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Cosentyx | $207 | 13 payments
|
| Abbvie | Rinvoq | $14 | 1 payment
|
See all 14 published payments
| Novartis Pharmaceuticals | Meals · 2025-12-22 | Cosentyx | $26 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $14 |
| Novartis Pharmaceuticals | Meals · 2025-11-19 | Cosentyx | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-22 | Cosentyx | $24 |
| Novartis Pharmaceuticals | Meals · 2025-07-22 | Cosentyx | $7 |
| Novartis Pharmaceuticals | Meals · 2025-06-27 | Cosentyx | $22 |
| Novartis Pharmaceuticals | Meals · 2025-06-24 | Cosentyx | $31 |
| Novartis Pharmaceuticals | Meals · 2025-04-10 | Cosentyx | $14 |
| Novartis Pharmaceuticals | Meals · 2025-03-20 | Cosentyx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-02-25 | Cosentyx | $7 |
| Novartis Pharmaceuticals | Meals · 2025-01-30 | Cosentyx | $12 |
| Novartis Pharmaceuticals | Meals · 2025-01-21 | Cosentyx | $6 |
| Novartis Pharmaceuticals | Meals · 2025-01-21 | Cosentyx | $4 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Cosentyx | $16 |
See earlier years (2024, 2022, 2019)
2024: $68
| Novartis Pharmaceuticals | Cosentyx | $68 | 3 payments
|
2022: $120
| GlaxoSmithKline | None | $120 | 1 payment
|
2019: $44
| Amgen | Enbrel | $44 | 1 payment
|
Professional record
- NPI
- 1548326606
- Licence
- CA A83950California A83950: Current · expires 2027-07-31
- Trained
- University of Texas Southwestern Medical School at Dallas, 2002
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-12-30
- NPI last updated
- 2024-08-30
- NPI record certified
- 2024-08-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301